FDA May Speed Drug Ad Review For Fee

Law360, New York (November 21, 2006, 12:00 AM EST) -- The U.S. Food and Drug Administration has reached a tentative agreement with pharmaceutical companies that would allow companies to pay the FDA fees to inspect their television ads in exchange for a speedier review.

Fees from the deal would help pay for the new staff needed to review the industry’s TV ads, the Wall Street Journal reported.

The FDA's Division of Drug Marketing, Advertising and Communications was recently restructured to address the ever-increasing workload of reviewing direct-to-consumer advertising materials.

In early September, the original DTC review...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.